Yoona Kim

Yoona Kim is a prominent figure in the healthcare technology sector, serving as the Co-founder and CEO of Arine, a company dedicated to addressing medication mismanagement through advanced data science and clinical expertise. Based in San Francisco, California, she has been leading Arine since its inception in January 2018, focusing on creating an AI-driven platform that optimizes medication therapy for patients.1

Educational Background

Yoona Kim holds an impressive academic portfolio:

• Bachelor’s Degree in Human Biology from Stanford University.
• Doctor of Pharmacy (Pharm.D.) with a focus on Health Policy and Management from the University of California, San Francisco.
• Ph.D. in Health Economics and Outcomes from The University of Texas at Austin.13

Professional Experience

Before founding Arine, Yoona accumulated extensive experience in various roles within the healthcare industry:

• Research Advisor at Stanford University since March 2014.
• Head of Clinical Modeling and Analytics at Proteus Digital Health from April 2014 to October 2017.
• Associate Director for Global Health Economics and Outcomes Research at Gilead Sciences from October 2012 to April 2014.1

Contributions at Arine

Under Yoona's leadership, Arine has developed a robust platform that utilizes AI to deliver personalized medication management solutions. The platform has successfully generated over 33 million recommendations for more than 15 million patients, significantly improving patient outcomes and reducing hospital admissions by up to 40%.35 The company has grown rapidly, doubling its workforce and expanding its reach in the healthcare market.24

Vision and Impact

Yoona Kim is passionate about leveraging technology to enhance patient care, particularly addressing disparities in medication adherence among diverse populations. Her work emphasizes the integration of clinical insights with socioeconomic data to tailor interventions that meet individual patient needs effectively.56

Overall, Yoona Kim exemplifies a commitment to revolutionizing healthcare practices through innovative solutions that bridge gaps in medication management, ultimately aiming for better health outcomes across various demographics.